Advanced Enzyme Technologies Ltd (NSE: ADVENZYMES, BSE: 540025) is a Thane, Maharashtra-based company in the Enzymes and Industrial Biotechnology industry. With a market capitalisation of ₹2,990 Cr, it ranks #1,047 by market cap among the 6,137 Indian listed companies on FinBizNet. At ₹248.35 (as of 25 Oct 2026), the share price is 40.7% below its 52-week high of ₹419.00 and 0.6% above its 52-week low of ₹246.85. The share price is down 19.8% over one year and down 21.7% over three months.
| Current Price | ₹248.35 |
|---|---|
| Market Cap | ₹2,990 Cr |
| NSE Symbol | ADVENZYMES |
| BSE Code | 540025 |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Enzymes and Industrial Biotechnology |
| P/E Ratio | 17.5 |
| Return on Equity | 11.02% |
| Return on Assets | 6.85% |
| 52-Week Range | ₹246.85 – ₹419.00 |
| 1-Year Price Change | -19.8% |
| 3-Month Price Change | -21.7% |
| Beta (1Y) | 0.37 |
| Dividend Yield | 1.02% |
| Headquarters | Thane, Maharashtra |
| Website | www.advancedenzymes.com |
| Revenue | ₹190 Cr |
|---|---|
| Net Profit | ₹39 Cr |
| Net Margin | 20.3% |
| EPS (Basic) | ₹3.31 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications, biofuels, and bio-catalysis. It also provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is headquartered in Thane, India.
1. Manufacturing and Sales of Enzymes-This segment researches and develops, manufactures, and markets enzymes and probiotics.
1. Manufacturing and Sales of Enzymes-100%
Advanced Enzyme Technologies Ltd is trading at ₹248.35, with a market capitalisation of ₹2,990 Cr.
Advanced Enzyme Technologies Ltd operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Enzymes and Industrial Biotechnology).
Advanced Enzyme Technologies Ltd has a P/E of 17.5 and a return on equity of 11.02%.
Advanced Enzyme Technologies Ltd is listed on the NSE under the symbol ADVENZYMES and on the BSE under the scrip code 540025.
Advanced Enzyme Technologies Ltd's share price is down 19.8% over one year and down 21.7% over three months. Its 52-week range is ₹246.85 to ₹419.00.
In Q1 FY27, Advanced Enzyme Technologies Ltd reported revenue of ₹190 Cr and net profit of ₹39 Cr, with basic EPS of ₹3.31 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.